Cargando…

Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea

INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdogan, Hilal Kaya, Bulur, Isil, Kocaturk, Evin, Saracoglu, Zeynep Nurhan, Alatas, Ozkan, Bilgin, Muzaffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041719/
https://www.ncbi.nlm.nih.gov/pubmed/30008650
http://dx.doi.org/10.5114/ada.2018.76228
_version_ 1783339034437746688
author Erdogan, Hilal Kaya
Bulur, Isil
Kocaturk, Evin
Saracoglu, Zeynep Nurhan
Alatas, Ozkan
Bilgin, Muzaffer
author_facet Erdogan, Hilal Kaya
Bulur, Isil
Kocaturk, Evin
Saracoglu, Zeynep Nurhan
Alatas, Ozkan
Bilgin, Muzaffer
author_sort Erdogan, Hilal Kaya
collection PubMed
description INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and advanced oxidation protein products (AOPP) levels in our study. MATERIAL AND METHODS: Our study included rosacea patients and healthy volunteers aged between 18 and 65 years. Total antioxidant status, TOS and AOPP levels were measured and OSI was calculated. RESULTS: The study included 70 rosacea patients and 30 healthy volunteers as a control group. When TAS, TOS, OSI and AOPP levels were compared between rosacea and control groups, there was no difference for OSI levels; while TAS, TOS and AOPP levels were significantly higher in the rosacea group (p = 0.151, p = 0.013, p = 0.034, p = 0.017, respectively). In the rosacea group, there was no correlation between TAS, TOS, OSI and AOPP levels and disease duration. Besides there was no difference between family history, rosacea type, symptom frequency and ocular involvement and TAS, TOS, OSI and AOPP levels in the rosacea group. CONCLUSIONS: We observed that serum TAS, TOS and AOPP levels were significantly higher in rosacea patients, but there was no significant difference among the disease activity parameters. These results can support the role of oxidative stress in the pathogenesis of rosacea.
format Online
Article
Text
id pubmed-6041719
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-60417192018-07-13 Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea Erdogan, Hilal Kaya Bulur, Isil Kocaturk, Evin Saracoglu, Zeynep Nurhan Alatas, Ozkan Bilgin, Muzaffer Postepy Dermatol Alergol Original Paper INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and advanced oxidation protein products (AOPP) levels in our study. MATERIAL AND METHODS: Our study included rosacea patients and healthy volunteers aged between 18 and 65 years. Total antioxidant status, TOS and AOPP levels were measured and OSI was calculated. RESULTS: The study included 70 rosacea patients and 30 healthy volunteers as a control group. When TAS, TOS, OSI and AOPP levels were compared between rosacea and control groups, there was no difference for OSI levels; while TAS, TOS and AOPP levels were significantly higher in the rosacea group (p = 0.151, p = 0.013, p = 0.034, p = 0.017, respectively). In the rosacea group, there was no correlation between TAS, TOS, OSI and AOPP levels and disease duration. Besides there was no difference between family history, rosacea type, symptom frequency and ocular involvement and TAS, TOS, OSI and AOPP levels in the rosacea group. CONCLUSIONS: We observed that serum TAS, TOS and AOPP levels were significantly higher in rosacea patients, but there was no significant difference among the disease activity parameters. These results can support the role of oxidative stress in the pathogenesis of rosacea. Termedia Publishing House 2018-06-18 2018-06 /pmc/articles/PMC6041719/ /pubmed/30008650 http://dx.doi.org/10.5114/ada.2018.76228 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Erdogan, Hilal Kaya
Bulur, Isil
Kocaturk, Evin
Saracoglu, Zeynep Nurhan
Alatas, Ozkan
Bilgin, Muzaffer
Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title_full Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title_fullStr Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title_full_unstemmed Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title_short Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
title_sort advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041719/
https://www.ncbi.nlm.nih.gov/pubmed/30008650
http://dx.doi.org/10.5114/ada.2018.76228
work_keys_str_mv AT erdoganhilalkaya advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea
AT bulurisil advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea
AT kocaturkevin advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea
AT saracogluzeynepnurhan advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea
AT alatasozkan advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea
AT bilginmuzaffer advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea